APPLICATIONS PUBLISHED 17 MARCH 2004
Published: 1-Sep-2004
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492
Delivery of small hydrophilic molecules packaged into lipid vesicles
Applied NanoSystem 1397123*
Use of antidiabetics for making a medicine with cicatrising effect
Merck Sante 1397124*
Compressible guaifenesin compsns and method for producing them
Rhodia 1397125*
Method of delaying ejaculation
DMI Biosciences 1397126*
Solid pharmaceutical formulations comprising modafinil
Cephalon 1397127*
Kappa opiate agonists for the treatment of bladder diseases
Merck Patent 1397128*
Heteroaryloxy 3-substituted propanamines S serotonin and norepinephrine reuptake inhibitors
Eli Lilly 1397129*
Substituted indole acid derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1)
Wyeth 1397130*
Compsns and comprising nitrofurantoin and Uva Ursi
Procter & Gamble 1397131*
Pirenzepine ophthalmic gel
Valley Forge Pharmaceuticals 1397132*
Rapid onset formulation
Duschesnay 1397133*
Combination of a dopamine D2-receptor agonist and triotropium or a derivative thereof for treating obstructive airways
Boehringer Ingelheim Pharma 1397134*
Combination of a PDE4 inhibitor and tiotropium or derivative thereof for treating obstructive airways
Boehringer Ingelheim Pharma 1397135*
Heterocyclic beta-aminoacids and their use as anti-epileptogenic agents
Queen's University at Kingston 1397136*
Hydantoin derivatives as inhibitors of matrix metalloproteinases
Bristol-Myers Squibb 1397137*
Active ingredient combination for treating a dependence on addictive substances or narcotics using medicaments
HF Arzneimittelforschung 1397138*
Pharmaceutical combinations
AstraZeneca 1397139*
Combination of an adenosine A2A-receptor agonist and tiotropium or a derivative thereof for treating obstructive airways
Boehringer Ingelheim Pharma 1397140*
Use of compounds with combined NEP/MP-inhibitory activity in the preparation of medicaments
Solvay Pharmaceuticals 1397141*
Pyrimidine inhibitors of phosphodiesterase
Bristol-Myers Squibb 1397142*
Estriol therapy for multiple sclerosis and other autoimmune diseases
The Regents of the University of California 1397143*
Use of COX-2 inhibitors for the treatment of schizophrenia, delusional disorders, affective disorders, autism or TIC disorders
Mueller, Norbert 1397145*
Compsns and methods for inhibiting bone resorption
Merck 1397146*
Use of adenosine A1 agonists in the treatment of emesis
Glaxo Group 1397147*
Chromium/biotin treatment of dyslipidaemia and diet-induced post-prandial hyperglycaemia
Nutrition 21 1397148*
Nerium oleander extract, compsns containing the nerium oleander L extract and a method of preparation of this extract
S A V Virex 1397149*
Somatostatin agonists
The Administrators of the Tuiane Educational Fund 1397150*
WNV Core protein/capsid interacting protein and uses of the same
The Trustees of the University of Pennsylvania 1397151*
Use of tripeptide GPE for treating or preventing symptoms of Parkinson's disease
Neuronz 1397152*
Methods for protecting allogeneic islet transplant using soluble CTLA4 mutant molecules
Bristol-Myers Squibb 1397153*
Abin-mediated hepatitis protection
Vlaams Interuniversitaur Instituut voor Biotechnologie 1397154*
Sustained release formulation
Genentech 1397155*
Oral administration of parathyroid hormone and calcitonin
Novartis 1397156*
Antibacterial agent
Novologix 1397157*
Use of IGM antibodies against DSDNA in systemic lupus erythematosus with nephritis
Witte, Torsten 1397158*
Stable liquid formulations of antibodies
Novartis 1397159*
Pharmaceutical compsn including ACE/NEP inhibitors and bioavailability enhancers
Shire Laboratories 1397160*
Compounds comprising an analgesic molecule linked to a vector that can vectorise said molecule through the hematoencephalic barrier and pharmaceutical compsns containing same
Synt:em 1397161*
Water-soluble antibiotic comprising an amino sugar, in the form of a polysaccharide conjugate
Fresenius Kabi Deutschland 1397162*
Method for the diagnosis and therapy of stem cell carcinoma
Daniel, Peter 1397163*
Sealing element
Arzneimittel 1397164*
(Ethylene)-(propylene)-triaminepentaacetic acid derivatives, process for their production, and their use for the production of pharmaceutical agents
Schering 1397339*
Chemical compounds and pharmaceutical compsns as cathepsin S inhibitors
Axys Pharmaceuticals; Aventis Pharmaceuticals 1397340*
6-(aryl-amido or aryl-amidomethyl)-naphthalen-2-yloxy-acidic derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1)
Wyeth 1397341*
Process for preparing sertraline intermediates
Orion Corp 1397342*
Process for preparing sertraline hydrochloride polymorphic form II
Orion Corp Fermion 1397343*
Process for the preparation of cyclohexanol derivatives
Wyeth 1397344*
Method of the hemihydrogenation of dinitriles in order to form aminonitriles
Rhodia Polyamide Intermediates 1397345*
Method for the hemihydrogenation of dinitriles in order to form aminonitriles
Rhodia Polyamide Intermediates 1397346*
Preparation of 17-phenyl- 18, 19, 20-trinor-PGF2A and its derivatives
Finetech Laboratories 1397347*
Factor XA inhibitor
Eli Lilly 1397348*
4-imino-N-alkoxy or oxy-polyalkyl-piperidine compounds and their use as polymerisation regulators
Ciba Specialty Chemicals 1397349*
Isoquinolinone derivatives as PARP inhibitors
Kudos Pharmaceuticals; Maybridge 1397350*
Pyrimidine, triazine and pyrazine derivatives as glutamate receptors
F Hoffmann-La Roche 1397351*
Process for the isolation of monophenolic-bisaryl triazines
Cytec Technologies 1397352*
2-(2,6-disubstituted phenyl)-4-aryl-5-alkyl-1,3-oxazoline compounds useful as insecticides and acaricides
Dow Agrosciences 1397353*
Imidazole-2-carboxamide derivatives as RAF kinase inhibitors
SmithKline Beecham 1397354*
Pyridyl cyanoguanidine compounds
Leo Pharma 1397355*
Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1)
Wyeth 1397356*
Polymorphic forms of 1-4'-(5-cyanoindol-3-yl)butyl-4-(2-carbamoylbenzofuran-5-yl)-piperazine hydrochloride
Merck Patent 1397357*
Tropane derivatives and their use as monoamine neurotransmitter reuptake inhibitors
Neurosearch 1397358*
1-biaryl-1,8-naphthyridin-4-one phosphodiesterase-4 inhibitors
Merck Frosst Canada 1397359*
Azaindoles
Aventis Pharma 1397360*
Carboline derivatives as PDEV inhibitors
Lilly Icos 1397361*
Triazolopyrimidines having a fungicidal effect
Bayer CropScience 1397362*
5-ethyl-imidazotraizinones
Bayer HealthCare 1397363*
Novel pyrrole derivatives as pharmaceutical agents
Eli Lilly 1397364*
Novel heteroaryl-diazabicyclo-alkanes as CNS-modifiers
NeuroSearch 1397365*
Novel ligand for nicotinic acetylcholine receptors useful in therapy
AstraZeneca 1397366*
Broad spectrum 2-(substituted-amino)-benzoxalone sulphonamide HIV protease inhibitors
Tibotec Pharmaceuticals 1397367*
New use of specific cyclolignans
Axelar 1397368*
New use of cyclolignans and new cyclolignans
Axelar 1397369*
B-benzyloxyasparate derivatives with amino group on benzene ring
Suntory 1397370*
Improved synthesis of allofuranose
Santaris Pharma 1397373*
Siglec inhibitors
Kelm, Soerge 1397374*
Alkyl- and/or alkenyloligoglycoside preparations having reduced magnesium salt concentrations
Cognis Deutschland 1397375*
Method for producing perbenzylated 1-O-glycosides
Schering 1397376*
